Hypoxanthine
Specifications
68-94-0CAS Number
200-697-3EC Number
1,7-dihydropurin-6-oneIUPAC Name
C5H4N4OChemical Formula
136.11 g/molMolecular Weight
hypoxanthine; 68-94-0; 6-Hydroxypurine; 9H-Purin-6-ol; 7H-Purin-6-ol; Sarkin; 3H-Purin-6-ol; Sarcine; 1,7-Dihydro-6H-purin-6-one; 6-Oxopurine; Sarkine; Hypoxanthine enol; Purin-6(1H)-one; Purin-6-ol; 6-Hydroxy-1H-purine; 9H-Purin-6(1H)-one; 6(1H)-Purinone; Purin-6(3H)-one; 6H-Purin-6-one, 1,7-dihydro-; Purine-6-ol; 6,7-dihydro-3H-purin-6-one; DTXSID8045983; CHEBI:17368; 2TN51YD919; NSC-14665; DTXCID6025983; NSC14665; RefChem:789621; 200-697-3; 1h-purin-6-ol; 1,9-dihydro-6H-purin-6-one; 1,7-Dihydro-6H-purine-6-one; 146469-94-5; 3,7-dihydropurin-6-one; 95121-06-5; 146469-95-6; 51953-04-9; 146445-70-7; 1H-Purin-6-ol (9CI); 6H-Purin-6-one, 1,9-dihydro-; 9H-Purin-6-ol (VAN); MFCD00005725; 6H-Purin-6-one, 3,7-dihydro- (9CI); HX; NSC 14665; AI3-52242; CHEMBL1427; NCGC00095622-01; Discontinued. See H998503 or H998504; Hypoxsanthine (1,7-Dihydro-6H-purin-6-one); 1H-Purin-6(9H)-one; F1386-0269; CAS-68-94-0; 146469-96-7; Hypoxanthine (VAN); 1,7-Dihydro-6H-purin-6-one (Hypoxanthine); purin-6(1H)-on; EINECS 200-697-3; Hypoxanthinee; UNII-2TN51YD919; 3h-hypoxanthine; 6-hydroxypurin; 6-oxypurine; 6-purinol; 1vfn; 3nrz; Hypoxanthine, 99%; purine, 6-hydroxy-; 1H,7H-Hypoxanthine; NSC 129419; 4-Hydroxy-1H-purine; Spectrum_001417; 1a9q; Hypoxanthine (Standard); 7H-Purin-6-ol #; SpecPlus_000461; Spectrum2_001907; Spectrum3_001352; Spectrum4_001742; Spectrum5_000564; HYPOXANTHINE [MI]; 1,9-dihydropurin-6-one; Didanosine impurity A CRS; 3H-Purin-6(9H)-one; bmse000094; Epitope ID:167471; 1,9-Dihydro-purin-6-one; Hypoxanthine, >=99.0%; DIDANOSINE IMPURITY A; SCHEMBL25381; SCHEMBL25382; SCHEMBL25383; BSPBio_003163; KBioGR_002184; KBioSS_001897; Mercaptopurine EP Impurity A; SPECTRUM310023; 51953-23-2; Hypoxanthine (VAN) (8CI); DivK1c_006557; HYPOXANTHINE [WHO-DD]; Mercaptopurine impurity A CRS; SCHEMBL158472; SCHEMBL158473; SCHEMBL275944; SCHEMBL275945; SCHEMBL355917; SCHEMBL440223; SCHEMBL446722; SCHEMBL822613; SPBio_001874; GTPL4555; orb1224235; orb1308844; orb3025461; SCHEMBL1867923; SCHEMBL3245216; SCHEMBL3696833; SCHEMBL4361878; SCHEMBL8012415; SCHEMBL8079826; SCHEMBL8169178; SCHEMBL9043222; SCHEMBL9047405; 6,7-dihydro-1H-purin-6-one; 3,7-Dihydro-6H-purin-6-one; 3,9-Dihydro-6H-purin-6-one; SCHEMBL14793560; SCHEMBL17276814; SCHEMBL21332344; SCHEMBL30633160; BDBM82018; FDGQSTZJBFJUBT-UHFFFAOYSA-; HY-N0091R; KBio1_001501; KBio2_001897; KBio2_004465; KBio2_007033; KBio3_002383; CAS_790; MSK6923; NSC_790; HMS5087P17; 6H-Purin-6-one, 3,7-dihydro-; 6H-Purin-6-one, 3,9-dihydro-; SMSSF-0040850; FDC26504; HY-N0091; Tox21_111511; CCG-38478; EBC-06261; EBC-48055; MSK6923-100W; PDSP1_000299; PDSP2_000297; s2424; SBB004203; STK804424; AKOS000267572; AKOS005221762; AKOS009159101; AKOS015888571; AKOS022168213; MSK6923-1000W; Tox21_111511_1; DB04076; FH02949; PS-3167; SDCCGMLS-0065594.P001; SDCCGMLS-0065594.P002; NCGC00095622-04; AC-10518; AC-32451; SY012477; Hypoxanthine Solution in Water, 100ug/mL; DB-029904; DB-264101; DB-273114; DB-273118; DB-273292; DB-325530; DIDANOSINE IMPURITY A [EP IMPURITY]; Hypoxanthine Solution in Water, 1000ug/mL; AZATHIOPRINE IMPURITY F [EP IMPURITY]; CS-0007792; H0311; H9763; NS00010150; ST50160486; SW219908-1; EN300-37579; Hypoxanthine, Vetec(TM) reagent grade, 98%; C00262; Hypoxanthine, Low endotoxin: <= 0.04 EU/mg; M01853; AB00674258-01; AC-907/21098001; AG-670/31547063; Q410305; SR-05000002375; SR-05000002375-1; Azathioprine EP Impurity F; Didanosine EP Impurity A; BRD-K03739921-001-06-8; Z1954805546; Hypoxanthine, powder, BioReagent, suitable for cell culture; MERCAPTOPURINE IMPURITY, HYPOXANTHINE- [EP IMPURITY]; 8C229956-6BE8-4F8D-91B7-0AD1EC294077; MERCAPTOPURINE IMPURITY, HYPOXANTHINE- [USP IMPURITY]; Tenofovir disoproxil Impurity 40(Azathioprine EP Impurity F); Didanosine impurity A,, European Pharmacopoeia (EP) Reference Standard; InChI=1/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)Synonyms
